HeyJaredRahul Rao
- Indexed articles, last 90 days
- 2
- Latest publication
- Jul 30, 2026
- Outlet visibility, for The Indian Express
- Top 5K sites
- Earliest in this view
- Jul 22, 2026
Latest articles
Sona Comstar is betting on a 10x decade. Can execution match the ambition? (opens the original)
Read excerpt
On July 22, 2026, a Gurugram-based auto components company announced it was selling a business it had spent a decade building — its 2W and 3W EV drivetrain unit — for Rs 893 crore to its own subsidiary, and then handed 49% of that subsidiary to Denso, the $45-billion Japanese powertrain giant, at an enterprise value of Rs 1,750 crore. Twenty-four hours later, on its Q1 FY27 earnings call, the same company unveiled ‘Sona Comstar 2.0’. It disclosed that its brand-new robotics vertical had already
Concord Biotech: A bad year or a bigger opportunity? (opens the original)
Read excerpt
Organ transplant patients depend on immunosuppressant drugs such as Tacrolimus, Mycophenolate and Cyclosporine to prevent their immune systems from rejecting the transplanted organ. Missing these medicines for too long can lead to organ rejection. A significant share of the active pharmaceutical ingredients (APIs) used in these drugs is produced through fermentation — a process in which microorganisms are cultivated in large steel tanks under precisely controlled conditions. Concord Biotech Limi
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5K sites
For The Indian Express, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.